Percentage of Myeloid Dendritic Cells in Peripheral Venous Blood Is Negatively Related to Incidence of Graves’ Orbitopathy

Table 1

Characteristics of patients and controls included in the study.

Characteristics	Active GO patients ()	Inactive GO patients ()	Controls ()	GD without GO ()
Age at study enrollment,
Gender
Female	14	7	12	6
Male	3	1	3	2
TSH (mIU/L)
Free T3 (pg/mL)
Free T4 (ng/dL)
Euthyroid^a
Yes	12	5	15	1
No	5	3	0	7
TR-Ab^b (IU/L)
Positive	17	6	0	8
Negative	0	2	9	0
Unknown	0	0	6	0
TPO-Ab^c (IU/mL)
Positive	8	4	0	6
Negative	9	3	9	0
Unknown	0	1	6	1
Tg-Ab^d (IU/mL)
Positive	5	4	0	3
Negative	12	3	9	3
Unknown	0	1	6	2
CAS
>3	17	0
<3	0	8
Antithyroid treatment
Yes	15	3		7
No	2	5		1
L-Thyroxine
Yes	1	2		0
No	16	6		8
^131I
Yes	2	0		0
No	15	8		8
Surgery
Yes	1	1		0
No	16	7		8
Smoking
Yes	14	3		1
No	0	5		0
Unknown	3	0		7
MRI
Active	12	0
Inactive	0	6
Unknown	5	2

^aPatients were considered euthyroid when TSH is 0.27–4.2 mIU/L, FT3 is 2.6-4.4 pg/mL, and FT4 is 0.93–1.7 ng/dL. ^bTR-Ab TSH receptor antibody, negative <1.75 IU/L. ^cTPO-Ab thyroid peroxidase antibody, negative <34 IU/mL. ^dTg-Ab thyroglobulin antibody, negative <115 IU/mL.